Filter by:

Sector ▼

Stage ▼

Service ▼


  • CAD $56,000,000
    adMare BioInnovations
    MERGER & ACQUISTION ADVISORY MARCH 2020

  • CAD $35,000,000
    Medicenna Therapeutics Corp.
    PUBLIC OFFERING MARCH 2020

  • CAD $10,250,000
    Appili Therapeutics Inc.
    PUBLIC OFFERING FEBRUARY 2020
  • Aurinia Pharmaceuticals
    MONETIZATION PLANNING JANUARY 2020

  • US $116,955,000
    Trillium Therapeutics Inc.
    Public Offering JANUARY 2020

  • US $60,000,000
    Xenon Pharmaceuticals Inc.
    Public Offering JANUARY 2020
  • Neoleukin Therapeutics
    MONETIZATION PLANNING DECEMBER 2019

  • US $191,700,000
    Aurinia Pharmaceuticals
    PUBLIC OFFERING DECEMBER 2019

  • CAD $3,000,000
    Klinik Health Ventures Corp.
    IPO DECEMBER 2019

  • CAD $18,000,000
    BEACON™
    SERIES A FOLLOW-ON NOVEMBER 2019

  • CAD $6,900,000
    Medicenna Therapeutics Corp.
    PUBLIC OFFERING OCTOBER 2019

  • USD $70,000,000
    Bellus Health
    U.S. IPO SEPTEMBER 2019

  • USD $36,000,000
    ESSA Pharma Inc.
    PUBLIC OFFERING; PRIVATE PLACEMENT AUGUST 2019

  • USD $35,000,000
    Titan Medical Inc.
    COMMON SHARE PURCHASE AGREEMENT AUGUST 2019

  • CAD $8,050,000
    Antibe Therapeutics Inc.
    PUBLIC OFFERING AUGUST 2019

  • CAD $15,200,000
    Resverlogix Corp.
    EQUITY OFFERING JUNE 2019

  • CAD $50,025,008
    HLS Therapeutics Inc.
    BOUGHT DEAL JUNE 2019

  • CAD $30,579,250
    Greenbrook TMS
    BOUGHT DEAL; PRIVATE PLACEMENT MAY 2019

  • CAD $5,260,000
    Avivagen
    PRIVATE PLACEMENT MARCH 2019

  • USD $28,750,000
    Titan Medical Inc.
    PUBLIC OFFERING MARCH 2019

  • CAD $3,586,813
    Appili Therapeutics Inc.
    PRIVATE PLACEMENT MARCH 2019
  • Aurinia Pharmaceuticals
    MONETIZATION PLANNING FEBRUARY 2019
  • CannTrust™
    MONETIZATION PLANNING JANUARY 2019

  • USD $110,000,000
    Nuvo Pharmaceuticals Inc.
    MERGER & ACQUISTION ADVISORY DECEMBER 2018

  • CAD $4,000,000
    Medicenna Therapeutics Corp.
    Public Offering DECEMBER 2018

  • CAD $35,000,000
    Bellus Health
    EQUITY OFFERING DECEMBER 2018
  • Aurinia Pharmaceuticals
    MONETIZATION PLANNING OCTOBER 2018

  • UP TO CAD $88,000,000
    Pediapharm Inc.
    Merger & Acquisition Advisory OCTOBER 2018

  • USD $ 63,000,000
    Xenon Pharmaceuticals Inc.
    Public Offering SEPTEMBER 2018

  • CAD $9,150,000
    LED Medical Diagnostics Inc.
    Private Placement SEPTEMBER 2018

  • CAD $10,000,000
    Hamilton Thorne Ltd.
    BOUGHT DEAL; PRIVATE PLACEMENT AUGUST 2018

  • USD $19,198,935
    Titan Medical Inc.
    PUBLIC OFFERING AUGUST 2018

  • CAD $16,000,000
    Mimi’s Rock
    DEBT FINANCING JULY 2018

  • CAD $20,000,000
    Mimi’s Rock
    PRIVATE PLACEMENT JULY 2018
  • U.S. R&D Institute
    MONETIZATION PLANNING JUNE 2018

  • USD $20,000,000
    Greenbrook TMS
    PRIVATE PLACEMENT JUNE 2018

  • CAD $100,395,000
    CannTrust™
    BOUGHT DEAL JUNE 2018
  • Multinational Pharmaceutical Company
    MONETIZATION PLANNING MAY 2018
  • Multinational Pharmaceutical Company
    MONETIZATION PLANNING MAY 2018

  • CAD $6,184,647
    Kneat Software
    PRIVATE PLACEMENT APRIL 2018

  • CAD $10,139,988
    Titan Medical Inc.
    PUBLIC OFFERING APRIL 2018

  • CAD $27,797,275
    Sunniva Inc.
    BOUGHT DEAL; PUBLIC OFFERING MARCH 2018

  • CAD $14,375,000
    Immunovaccine Inc.
    BOUGHT DEAL FEBRUARY 2018
  • Satellos Bioscience
    Company Creation 2018

  • USD $26,040,000
    ESSA Pharma Inc.
    PUBLIC OFFERING JANUARY 2018
  • Precision Nutrition
    MERGER & ACQUISTION ADVISORY DECEMBER 2017

  • CAD $20,000,000
    Bellus Health
    PUBLIC EQUITY OFFERING DECEMBER 2017

  • CAD $23,000,000
    Titan Medical Inc.
    PUBLIC OFFERING DECEMBER 2017

  • CAD $4,000,000
    Avivagen
    PRIVATE PLACEMENT NOVEMBER 2017

  • CAD $20,000,000
    CannTrust™
    BOUGHT DEAL; PRIVATE PLACEMENT NOVEMBER 2017

  • CAD $8,925,000
    Titan Medical Inc.
    PUBLIC OFFERING JUNE 2017

  • CAD $4,983,000
    Antibe Therapeutics Inc.
    PUBLIC OFFERING JUNE 2017

  • CAD $10,000,000
    Resverlogix Corp.
    PUBLIC OFFERING JUNE 2017
  • TechAlliance of Southwestern Ontario
    MONETIZATION PLANNING APRIL 2017

  • EUR €13,900,000
    Hamilton Thorne Ltd.
    MERGER & ACQUISTION ADVISORY APRIL 2017

  • CAD $12,500,000
    Hamilton Thorne Ltd.
    PRIVATE PLACEMENT APRIL 2017
  • Weed MD
    MONETIZATION PLANNING MAY 2017
  • Alberta Innovates
    MONETIZATION PLANNING MAY 2017
  • NeuPath Health
    Company Creation 2017

  • CAD $7,500,000
    Titan Medical Inc.
    PUBLIC OFFERING MARCH 2017
  • Alberta Innovates
    MONETIZATION PLANNING MARCH 2017
  • Aquinox Pharmaceuticals Inc.
    MONETIZATION PLANNING MARCH 2017

  • CAD $4,000,000
    Medicenna Therapeutics Corp.
    Private Placement March 2017

  • CAD $25,000,000
    CannTrust
    Private Placement February 2017

  • CAD $14,400,000
    LED Medical Diagnostics Inc.
    Private Placement February 2017

  • USD $10,250,000
    LED Medical Diagnostics Inc.
    MERGER & ACQUISITION ADVISORY FEBRUARY 2017

  • CAD $100,050,000
    Knight Therapeutics Inc.
    Bought Deal December 2016

  • CAD $10,000,000
    Medicenna Therapeutics Corp.
    Private Placement December 2016

  • CAD $5,004,000
    CannaRoyalty Corp.
    Private Placement OCTOBER 2016

  • CAD $10,000,000
    Newtopia Inc.
    Series A Financing OCTOBER 2016

  • CAD $11,428,000
    Titan Medical Inc.
    Public Offering OCTOBER 2016

  • CAD $6,000,000
    Red Leaf Medical Inc.
    MERGER & ACQUISITION ADVISORY SEPTEMBER 2016
  • Bellus Health Inc.
    MONETIZATION PLANNING SEPTEMBER 2016

  • Clementia Pharmaceuticals
    MONETIZATION PLANNING SEPTEMBER 2016
  • Response Biomedical Corp.
    MERGER & ACQUISITION ADVISORY AUGUST 2016

  • USD $107,000,000
    Noden Pharma Inc.
    Private Placement JULY 2016
  • Noden Pharma Inc.
    MERGER & ACQUISITION ADVISORY JULY 2016
  • Medicago Inc.
    MONETIZATION PLANNING JULY 2016

  • CAD $230,000,000
    Knight Therapeutics Inc
    Bought Deal JUNE 2016

  • CAD $15,000,000
    Titan Medical Inc.
    Public Offering APRIL 2016
  • Canadian Public Pharmaceutical Company
    Valuation Opinion MARCH 2016

  • CAD $82,980,000
    Nuvo Reserach Inc.
    Fairness Opinion MARCH 2016

  • CAD $12,080,000
    Titan Medical Inc.
    Private Offering FEBRUARY 2016
  • Medicenna Therapeutics Corp.
    MONETIZATION PLANNING FEBRUARY 2016

  • USD $148,000,000
    Tribute Pharmaceuticals Canada Inc.
    Merger & Acquisition Advisory FEBRUARY 2016
  • Canadian Public Biotech Company
    MERGER & ACQUISITION ADVISORY JANUARY 2016

  • CAD $12,300,000
    INTEGA Skin Sciences Inc.
    Debt JANUARY 2016

  • USD $15,000,000
    ESSA Pharma Inc.
    Private Placement JANUARY 2016
  • Appili Therapeutics
    Company Creation 2015
  • Grey Wolf Animal Health
    Company Creation 2015
  • Triumvira Immunologics Inc.
    Company Creation 2015
  • Medicago Inc.
    Monetization Planning NOVEMBER 2015

  • CAD $2,120,000
    LED Medical Diagnostics Inc.
    Public Offering NOVEMBER 2015

  • CAD $47,000,000
    Alveda Pharmaceuticals Inc.
    Merger & Acquisition Advisory NOVEMBER 2015
  • Arthritis Innovation Corporation
    Valuation Opinion October 2015

  • USD $200,000,000
    HLS Therapeutics Inc.
    Private Placement AUGUST 2015

  • USD $185,000,000
    HLS Therapeutics Inc.
    Syndicated Loan AUGUST 2015
  • Exerkine Corporation
    Merger & Aquisition Advisory AUGUST 2015

  • CAD $1,590,000
    Diagnos Inc.
    Private Placement JULY 2015

  • CAD $2,680,000
    Agility Health Inc.
    Public Offering JUNE 2015

  • CAD $4,020,000
    Medicure Inc.
    Bought Deal; Private Placement JUNE 2015

  • CAD $12,500,000
    Tribute Pharmaceuticals Canada Inc.
    Private Placement JUNE 2015

  • CAD $25,000,000
    Medical Futures Inc.
    Merger & Acquisition Advisory JUNE 2015

  • CAD $12,000,000
    Tribute Pharmaceuticals Canada Inc.
    Raising Capital & Financing MAY 2016

  • USD $55,150,000
    Trillium Therapeutics Inc.
    Public Offering APRIL 2015

  • CAD $24,010,000
    Profound Medical Corp.
    Private Placement APRIL 2015

  • CAD $5,500,000
    Pediapharm Inc.
    Private Placement MARCH 2015

  • CAD $27,370,000
    CRH Medical Corporation
    Bought Deal MARCH 2015
  • Qing Bile Therapeutics
    Company Creation 2015
  • Ontario Academic Institution
    Monetization Planning JANUARY 2015
  • Xenon Pharmaceuticals Inc.
    Monetization Planning JANUARY 2015

  • USD $12,000,000
    ESSA Pharma Inc.
    Private Placement JANUARY 2015
  • Pharmascience Inc.
    Monetization Planning JANUARY 2015

  • CAD $100,000,000
    Knight Therapeutics Inc.
    Bought Deal DECEMBER 2014

  • USD $52,000,000
    CRH Medical Corporation
    Debt DECEMBER 2014

  • USD $73,200,000
    CRH Medical Corporation
    Merger & Acquisition Advisory DECEMBER 2014

  • CAD $1,350,000
    Essa Pharma Inc.
    Private Placement OCTOBER 2014

  • USD $45,000,000
    Nuvo Research Inc.
    Merger & Acquisition Advisory OCTOBER 2014
  • iCo Therapeutics Inc.
    Monetization Planning OCTOBER 2014
  • TEC Edmonton
    Monetization Planning OCTOBER 2014

  • CAD $5,766,100
    Bioniche Life Sciences Inc.
    Private Placement SEPTEMBER 2014

  • CAD $3,400,000
    Essa Pharma Inc.
    Private Placement JULY 2014

  • CAD $30,026,500
    Tribute Pharmaceuticals Inc.
    Public Offering JULY 2014

  • CAD $3,000,000
    CannMedica Pharma Inc.
    Private Placement JULY 2014
  • Warnex Inc.
    MERGER & ACQUISITION ADVISORY MAY 2014
  • Plantform Corporation
    MONETIZATION PLANNING MAY 2014
  • McMaster University Faculty of Health Sciences
    MONETIZATION PLANNING MAY 2014

  • CAD $180,075,000
    Knight Therapeutics Inc.
    Private Placement APRIL 2014

  • CAD $3,400,000
    Agility Health Inc.
    Private Placement APRIL 2014
  • Antibe Therapeutics Inc.
    MONETIZATION PLANNING APRIL 2014

  • CAD $3,130,000
    Nuvo Research Inc.
    Private Placement APRIL 2014
  • Pediapharm Inc.
    Monetization Planning APRIL 2014
  • CPDC
    Monetization Planning MARCH 2014

  • CAD $3,020,000
    Antibe Therapeutics Inc.
    Raising Capital & Financing MARCH 2013

  • CAD $3,100,000
    Nuvo Pharmaceuticals Inc.
    Private Placement MARCH 2014

  • CAD $3,000,000
    Antibe Therapeutics Inc.
    Private Placement MARCH 2014
  • Bioniche Life Sciences Inc.
    MERGER & ACQUISITION ADVISORY MARCH 2014
  • Trillium Therapeutics Inc.
    MONETIZATION PLANNING MARCH 2014

  • CAD $8,000,000
    CannMedica Pharma Inc.
    Private Placement MARCH 2014
  • Xenon Pharmaceuticals Inc.
    Monetization Planning FEBRUARY 2014

  • CAD $7,530,000
    Triton Pharma Inc.
    Mergers & Acquisition Advisory JANUARY 2014

  • CAD $33,000,000
    Stem Cell Therapeutics Corp.
    Private Placement DECEMBER 2013
  • Sirona Biochem Corp.
    MONETIZATION PLANNING OCTOBER 2013

  • Approx. CAD $17,000,000
    STI Technologies Ltd.
    Private Equity Investment SEPTEMBER 2013

  • CAD $9,804,500
    Bioniche Life Sciences Inc.
    Public Offering SEPTEMBER 2013

  • Up to CAD $4,000,000
    Response Biomedical Corp.
    Private Placement SEPTEMBER 2013

  • Approx. CAD $357,000,000
    Medicago Inc.
    MERGER & ACQUISITION ADVISORY SEPTEMBER 2013
  • CIMTEC
    MONETIZATION PLANNING SEPTEMBER 2013
  • Aquinox Pharmaceuticals Inc.
    MONETIZATION PLANNING SEPTEMBER 2013

  • USD $6,000,000
    Tribute Pharmaceuticals Inc.
    Debt August 2013

  • Approx. CAD $13,000,000
    Thallion Pharmaceuticals Inc.
    MERGER & ACQUISITION ADVISORY August 2013

  • CAD $3,155,100
    Antibe Therapeutics Inc.
    Initial Public Offering JUNE 2013

  • CAD $3,379,520
    iCo Therapeutics Inc.
    Overnight Offering MAY 2013

  • CAD $40,000,000
    Trimel Pharmaceuticals Corp.
    Public Offering APRIL 2013

  • CAD $3,100,000
    Stem Cell Therapeutics Corp.
    Public Offering MARCH 2013
  • Victhom Human Bionics Inc.
    MERGER & ACQUISITION ADVISORY MARCH 2013
  • Tekmira Pharmaceuticals
    MONETIZATION PLANNING JANUARY 2013
  • CRH Medical Corp.
    MONETIZATION PLANNING JANUARY 2013

  • CAD $12,500,000
    Agility Health Inc.
    Private Placement DECEMBER 2012

  • Approx. USD 510,000,000
    YM BioSciences Inc.
    MERGER & ACQUISITION ADVISORY DECEMBER 2012
  • Ontario Institute for Cancer Research
    MONETIZATION PLANNING DECEMBER 2012
  • Warnex Inc.
    MERGER & ACQUISITION ADVISORY OCTOBER 2012
  • CML Healthcare Inc.
    MONETIZATION PLANNING OCTOBER 2012

  • USD $7,500,000
    Trimel Pharmaceuticals Corp.
    Venture debt JULY 2012

  • CAD $2,550,000
    iCo Therapeutics Inc.
    Overnight Offering JULY 2012
  • Pharmagap Inc.
    MERGER & ACQUISITION ADVISORY JULY 2012
  • Bellus Health Inc.
    MONETIZATION PLANNING JUNE 2012
  • Sirona Biochem Corp.
    MONETIZATION PLANNING JUNE 2012
  • Canadian Public Biotechnology Company
    MONETIZATION PLANNING JUNE 2012

  • CAD $8,000,000
    Nuvo Pharmaceuticals Inc.
    Secured Debt MAY 2012

  • USD $6,000,000
    Stellar Pharmaceuticals Inc.
    Secured Debt MAY 2012
  • Patient Home Monitoring Corp.
    MONETIZATION PLANNING APRIL 2012
  • Antibe Therapeutics Inc.
    MONETIZATION PLANNING JANUARY 2012

  • CAD $448,231
    Microbix Biosystems Inc.
    Public Offering DECEMBER 2011

  • Approx. CAD $10,000,000
    Stellar Pharmaceuticals Inc.
    MERGER & ACQUISITION ADVISORY DECEMBER 2011

  • CAD $3,520,000
    Botaneco Inc.
    Private Placement OCTOBER 2011

  • CAD $10,000,000
    Allon Therapeutics Inc.
    Public Offering OCTOBER 2011
  • Advitech Inc.
    MERGER & ACQUISITION ADVISORY OCTOBER 2011

  • CAD $25,000,000
    Medicago Inc.
    Private Placement SEPTEMBER 2011

  • CAD $2,200,000
    Lorus Therapeutics Inc.
    Public Offering AUGUST 2011

  • CAD $12,600,000
    Resverlogix Corp.
    Overnight Offering JUNE 2011
  • Nuvo Pharmaceuticals Inc.
    MONETIZATION PLANNING JUNE 2011

  • CAD $717,500
    Microbix Biosystems Inc.
    Private Placement APRIL 2011
  • Miraculins Inc.
    MONETIZATION PLANNING APRIL 2011

  • CAD $17,399,976
    Medicago Inc.
    Overnight Offering MARCH 2011

  • CAD $2,000,000
    Stem Cell Therapeutics Corp.
    Overnight Offering MARCH 2011

  • CAD $40,250,000
    Paladin Labs Inc.
    Bought Deal FEBRUARY 2011

  • CAD $1,808,866
    Ventripoint Inc.
    Private Placement JANUARY 2011

  • CAD $46,000,000
    YM Biosciences Inc.
    Public Offering DECEMBER 2010

  • CAD$ 5,000,000
    Agility Health Inc.
    Term Debt Financing DECEMBER 2010

  • CAD $28,777,600
    Oncolytics Biotech Inc.
    Bought Deal OCTOBER 2010

  • CAD $7,465,100
    ImmunoVaccine Inc.
    Public Offering SEPTEMBER 2010

  • CAD $7,500,000
    Medicago Inc.
    Overnight Offering AUGUST 2010
  • Miraculins Inc.
    MERGER & ACQUISITION ADVISORY AUGUST 2010

  • CAD $10,000,000
    Resverlogix Corp.
    Overnight Offering JUNE 2010

  • CAD $5,000,000
    Patient Home Monitoring Corp.
    Equity Line JUNE 2010

  • CAD $9,200,000
    Resverlogix Corp.
    Overnight Offering JUNE 2010

  • CAD $4,500,000
    Patient Home Monitoring Corp.
    Private Placement JUNE 2010
  • Patient Home Monitoring Corp.
    MERGER & ACQUISITION ADVISORY JUNE 2010

  • Approx. CAD $7,000,000
    DiaMedica Inc.
    MERGER & ACQUISITION ADVISORY JUNE 2010
  • Cipher Pharmaceuticals Inc.
    MONETIZATION PLANNING JUNE 2010
  • Medicago Inc.
    MONETIZATION PLANNING JUNE 2010

  • CAD $10,000,000
    Medicago Inc.
    Equity Line MAY 2010

  • USD $17,500,000
    YM Biosciences Inc.
    Registered Direct Offering MARCH 2010
  • Conjuchem LLC
    MERGER & ACQUISITION ADVISORY MARCH 2010

  • Approx. CAD $12,500,000
    YM Biosciences Inc.
    MERGER & ACQUISITION ADVISORY FEBRUARY 2010

  • CAD $8,000,000
    Resverlogix Corp.
    Private Placement JANUARY 2010
  • Medicure Inc.
    MERGER & ACQUISITION ADVISORY JANUARY 2010

  • CAD $25,000,000
    LaboPharm Inc.
    Equity Line NOVEMBER 2009

  • CAD $11,592,000
    Medicago Inc.
    Bought Deal NOVEMBER 2009

  • USD $14,662,500
    Oncolytics Biotech Inc.
    Overnight Offering NOVEMBER 2009

  • CAD $750,000
    Patient Home Monitoring Corp.
    Private Placement OCTOBER 2009

  • CAD $1,500,000
    Chemaphor Inc.
    Private Placement APRIL 2009
  • DRM Ventures Inc.
    MERGER & ACQUISITION ADVISORY OCTOBER 2009

  • CAD $500,000
    Med BioGene Inc.
    Private Placement SEPTEMBER 2009
  • Bradmer Pharmaceuticals Inc.
    MERGER & ACQUISITION ADVISORY JULY 2009

  • CAD $58,700,000
    Paladin Labs Inc.
    Bought Deal JUNE 2009
  • Med BioGene Inc.
    MERGER & ACQUISITION ADVISORY June 2009

  • CAD $380,000
    Chemaphor Inc.
    Private Placement APRIL 2009